We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The agency said further confirmatory testing should be conducted on products that are at risk of being contaminated with the potential carcinogen. Read More
A coalition of HIV advocacy groups challenged an attempt by Gilead Sciences to get out of a federal lawsuit against HIV drugmakers accused of delaying competition from generics and branded products. Read More
HHS on Friday submitted its proposed rule on prescription drug imports — a key part of the administration’s strategy to lower drug prices — to the Office of Management and Budget (OMB) for review. Read More